Antibiotice Iasi has inaugurated a 2.5 MW photovoltaic facility, a project funded by the Romanian Recovery and Resilience Plan (RRP).
Antibiotice Iași Company, a pharmaceutical manufacturer with Romanian capital, became a member of the Sustainable Romania Coalition, the first platform for sustainable development established by the Embassy of Sustainability in Romania (ASR).
The state-owned drug manufacturer Antibiotice Iași made total investments worth RON 27.17 million (€5.4 million) in the first six months of the year for sustainable development.
Antibiotice Iaşi Company, the largest Romanian producer of generic drugs, will build a 2.5 MW photovoltaic plant. The company announced that it obtained from the Ministry of Investments and European Projects financing of RON4.08 million (€816,000) in this regard.
It is still a long way to embedding ESG principles into corporate culture, operations, and decision-making processes. That was the main takeaway from a panel at CEE ESG Forum 2024 organised by Property Forum and Green Forum in Vienna last November.
FAN Courier, a leading Romanian logistics company, has allocated an investment budget of 40 million euros for 2025, including in renewable energy.
DRI, the European renewables division of Ukrainian energy company DTEK, has successfully connected its 60MW Glodeni II solar park to the Romanian grid.
NXP Semiconductors N.V. announced that it has secured a €1 billion loan from the EIB to advance the company's RDI investments across its broad portfolio of semiconductor solutions.
EIB and Societe Generale have agreed on a new initiative which has the potential to unlock investment of up to €8 billion to support wind energy manufacturers in Europe.
